The Well Estate will provide a turnkey solution for hospitality asset owners to be able to offer transformative medical wellness experiences to guests as the global hospitality industry seeks to harness the US$1.8 trillion global wellness boom. SINGAPORE–(BUSINESS WIRE)–Jun. 17, 2025 Seveno Capital and Borderless Healthcare Group have launched the world’s first medical wellness real […]
Category: Biomedical
Medisca Secures Settlement With FlackTek Reinforcing Patent Strength of MAZ® Mixer
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Jun. 10, 2025 Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the Medisca MAZ® mixer and related mixing technologies set forth in Medisca U.S. patent numbers 10,420,705, 10,765,600, 11,090,224, 11,096,864, 10,231,903, and 10,993,876. The confidential settlement resolves the pending litigation. “This settlement validates the investment Medisca has […]
Medical Korea 2025 to Discuss AI-powered Personalized Healthcare
Medical Korea 2025 to be held from March 20 (Thu) to March 23 (Sun), 2025, at COEX in Seoul, South Korea SEOUL, South Korea–(BUSINESS WIRE)–Mar. 17, 2025 Medical Korea 2025 (the 15th Global Healthcare & Medical Tourism Conference), hosted by the MOHW and organized by the KHIDI, will be held at Coex, Seoul, from March […]
Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 Pursuing two-pronged portfolio development strategy to establish strong foundation of critical injectable products while ensuring long-term competitiveness and return on investment Company to attend the 43rd Annual J.P. Morgan Healthcare Conference SCHAUMBURG, […]
STEERLife and Callidus Research Laboratories Forge Strategic Partnership to Accelerate Innovative Drug Development
BENGALURU, India–(BUSINESS WIRE)–Nov. 13, 2024 STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global markets. STEERLife is a division of STEER World. The collaboration combines STEERLife's advanced […]
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
NEW YORK–(BUSINESS WIRE)–Nov. 13, 2024 Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of […]
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
Expanded collaboration leverages Clinical Data Studio and AI-driven biometrics to deliver high-quality, efficient data services for Bioforum’s client LONDON–(BUSINESS WIRE)–Nov. 12, 2024 Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that serves clinical trial sponsors […]
Singapore’s National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapore’s Multi-Ethnic Population
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture and diversity in Singapore’s multi-ethnic Asia population through advanced, nanopore-based sequencing technology OXFORD, England–(BUSINESS WIRE)–Aug. 05, 2024 Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precision Health Research, […]
Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Jun. 27, 2024 Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York. The event was celebrated in the company of Medisca’s valued Plattsburgh team, business partners, and state and federal officials, including Congresswoman Elise […]
LC-Plasma-based Vaccine Research Selected for SCARDA Project
– Towards the Development of a Vaccine to prevent Respiratory Virus Infection – TOKYO–(BUSINESS WIRE)–May. 08, 2024 Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization against infectious diseases. We now announce that a […]
A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
MONTREAL–(BUSINESS WIRE)–Apr. 17, 2024 Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos and Maria Zaccardo, transition into strategic advisory roles as Chair and Vice Chair, respectively. Coinciding with the company’s 35th anniversary, this decision […]
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
Agreement spans wide range of Medidata’s solutions to enhance clinical trial efficiency NEW YORK–(BUSINESS WIRE)–Mar. 22, 2024 Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc. The agreement features […]